tiprankstipranks
Infant Bacterial Therapeutics AB (DE:9IB)
BERLIN:9IB
Germany Market

Infant Bacterial Therapeutics AB (9IB) Financial Statements

Compare
4 Followers

Infant Bacterial Therapeutics AB Financial Overview

Infant Bacterial Therapeutics AB's market cap is currently €43.76M. The company's EPS TTM is €-0.887; its P/E ratio is ―; Infant Bacterial Therapeutics AB is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenuekr 77.00Kkr 12.00Kkr 0.00kr 0.00kr 0.00
Gross Profitkr 77.00Kkr 12.00Kkr 0.00kr 0.00kr -816.00K
Operating Incomekr -134.62Mkr -65.81Mkr -44.58Mkr -71.92Mkr -47.20M
EBITDAkr 11.55Mkr -65.45Mkr -44.99Mkr -72.01Mkr -45.50M
Net Incomekr -123.07Mkr -65.09Mkr -45.40Mkr -72.31Mkr -47.05M
Balance Sheet
Cash & Short-Term Investmentskr 329.06Mkr 335.84Mkr 386.75Mkr 423.44Mkr 495.19M
Total Assetskr 351.33Mkr 349.62Mkr 408.48Mkr 450.32Mkr 518.27M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -329.06Mkr -335.84Mkr -386.75Mkr -423.44Mkr -495.19M
Total Liabilitieskr 46.18Mkr 17.91Mkr 13.22Mkr 10.16Mkr 7.88M
Stockholders' Equitykr 305.15Mkr 331.71Mkr 395.25Mkr 440.15Mkr 510.40M
Cash Flow
Free Cash Flowkr -101.22Mkr -85.80Mkr -55.62Mkr -58.39Mkr -51.30M
Operating Cash Flowkr -101.22Mkr -85.80Mkr -55.62Mkr -58.39Mkr -51.30M
Investing Cash Flowkr -4.15Mkr -1.00Kkr 0.00kr 0.00kr 0.00
Financing Cash Flowkr 96.52Mkr 1.88Mkr 91.00Kkr 1.76Mkr 0.00
Currency in SEK

Infant Bacterial Therapeutics AB Earnings and Revenue History

Infant Bacterial Therapeutics AB Debt to Assets

Infant Bacterial Therapeutics AB Cash Flow

Infant Bacterial Therapeutics AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis